money found for our users $0 and counting. see how it works
claimscout

Hair Relaxer Uterine Cancer Litigation

In litigation Mass-tort payouts ($50k+) mass_tort · pharma

Hair relaxer uterine and ovarian cancer MDL - rapidly growing case count

Eligibility hint
Used chemical hair relaxers or straighteners for several years and were diagnosed with uterine cancer, ovarian cancer, endometriosis, or uterine fibroids
Estimated payout range
$50,000 – $1,000,000
Current score
0.92 / 1.00
Official source
Following a 2022 NIH study linking chemical hair relaxer use to uterine cancer, MDL No. 3060 consolidated cases in the Northern District of Illinois. Defendants include L'Oreal, Strength of Nature, Namaste Laboratories, Godrej and Softsheen-Carson. Cases allege uterine cancer, ovarian cancer, endometriosis and uterine fibroids from long-term hair relaxer use, particularly among Black women starting in childhood.

Connected settlement administrations (1)

Recent signals

Brands: l'oreallorealsoftsheen-carsonstrength of naturenamastegodrejolaplex
Products: hair relaxerhair straightenerchemical relaxerperm

Think this might apply to you?
Take a 30-second audit and we'll match every brand you've used against active settlements.

Start audit →
Class action settlements pay out via:
🏦Bank transfer
Paper check
PayPal
Venmo
Zelle
💳Prepaid card
Apple Pay
Google Pay
The method is set by the administrator for each settlement, not by claimscout. We never touch the money.